REFERENCES
1. Murphy HR, Rayman G, Lewis K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ. 2008;337:a1680.
2. McLachlan K, Jenkins A, O’Neal D. The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy. Aust N Z J Obstet Gynaecol. 2007;47:186-90.
3. Yogev Y, Chen R, Ben-Haroush A, et al. Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstet Gynecol. 2003;101:633-8.
4. Secher AL, Madsen AB, Ringholm L, et al. Patient satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy in women with diabetes. Diabet Med. 2012;29:272-7.
5. Yu Q, Aris IM, Tan KH, et al. Application and Utility of Continuous Glucose Monitoring in Pregnancy: A Systematic Review. Front Endocrinol (Lausanne). 2019;10:697.
6. Su JB, Wang XQ, Chen JF, et al. Glycemic variability in gestational diabetes mellitus and its association with beta cell function. Endocrine. 2013;43:370-5.
7. Nigam A, Sharma S, Varun N, et al. Comparative analysis of 2-week glycaemic profile of healthy versus mild gestational diabetic pregnant women using flash glucose monitoring system: an observational study. BJOG. 2019;126 Suppl 4:27-33.
8. Dalfra MG, Sartore G, Di Cianni G, et al. Glucose variability in diabetic pregnancy. Diabetes Technol Ther. 2011;13:853-9.
9. Yu W, Wu N, Li L, et al. A Review of Research Progress on Glycemic Variability and Gestational Diabetes. Diabetes Metab Syndr Obes. 2020;13:2729-41.
10. Miller EM. Using Continuous Glucose Monitoring in Clinical Practice. Clin Diabetes. 2020;38:429-38.
11. Battelino T, Danne T, Bergenstal RM, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019;42:1593-603.
12. Blum A. Freestyle Libre Glucose Monitoring System. Clin Diabetes. 2018;36:203-04.
13. Yamamoto JM, Murphy HR. Benefits of Real-Time Continuous Glucose Monitoring in Pregnancy. Diabetes Technol Ther. 2021;23:S8-S14.
14. Huhn EA, Linder T, Eppel D, et al. Effectiveness of real-time continuous glucose monitoring to improve glycaemic control and pregnancy outcome in patients with gestational diabetes mellitus: a study protocol for a randomised controlled trial. BMJ Open. 2020;10:e040498.
15. Yu F, Lv L, Liang Z, et al. Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study. J Clin Endocrinol Metab. 2014;99:4674-82.
16. Feig DS, Donovan LE, Corcoy R, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017;390:2347-59.
17. Group. SKADMDftC. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. 2010.
18. International Association of D, Pregnancy Study Groups Consensus P, Metzger BE, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676-82.
19. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295:1681-7.
20. Teare MD, Dimairo M, Shephard N, et al. Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Trials. 2014;15:264.
21. Visser MM, Charleer S, Fieuws S, et al. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial. Lancet. 2021;397:2275-83.
22. Wang S, Xin H, Li L, et al. Time in range measurements for hyperglycemia management during pregnancy. Clin Chim Acta. 2022;531:56-61.
23. Preau Y, Armand M, Galie S, et al. Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices. Diabetes Technol Ther. 2021;23:259-67.
24. Heinemann L, Klonoff DC. An Opportunity to Increase the Benefit of CGM Usage: The Need to Train the Patients Adequately. J Diabetes Sci Technol. 2020;14:983-86.